Results for cranial translation from English to Maltese

cranial nerves
nervi kranjali

borr extra- cranial n (%)a
borr barra mill- kranju n (%)a

cranial irradiation (block 5 only)
irradjazzjoni kranjali (blokk 5 biss)

cranial neuropathy, loss of other senses5
newropatija kranjali, telf ta’ sensi oħra5

head,brain and cranial nerves and vessels
nervi u kanali tar-ras, tal-moħħ u tal-kranju

seizure, cranial nerve inflammation, impaired coordination or balance
aċċessjoni, infjammazzjoni tan-nerv kranjali, impediment fil-ko-ordinazzjoni jew bilanċ

start 6-mp the 1st day after cranial irradiation completion.)
ibda 6- mp fl-1el ġurnata wara t-tmiem tal-irradjazzjoni kranjali.)

6-10 days of cranial irradiation beginning on day 1 of cycle 5.
6-10 ijiem ta’ irrdjazzjoni kranjali mibdija fl-1 ġurnata ta’ Ċiklu 5.

cranial neuropathy, peripheral neuropathy facial nerve palsy4, loss of other senses4
newropatija kranjali, newropatija periferali, paralisi tan- nerv tal - wiċċ4, telf ta ’ sensi oħra4

uptake has also been identified in some cases in extracerebral structures such as scalp, salivary glands, muscles and cranial bone.
f’xi każijiet instab li kien hemm xi teħid minn strutturi ekstraċerebrali bħall-glandoli salivarji, mill-ġilda, mill-muskoli u fl-għadam.

although stunning by injection of gas in the cranial cavity is prohibited within the community, injection of gas may also occur after stunning.
għalkemm l-isturdament b’injezzjoni tal-gass fil-ħofra kranjali hu projbit fil-komunità, l-injezzjoni tal-gass tista’ sseħħ ukoll wara l-isturdament.

administration of depocyte in combination with other neurotoxic chemotherapeutic agents or with cranial/spinal irradiation may increase the risk of neurotoxicity.
l-għoti flimkien ta’ depocyte ma’ mediċini kimoterapewtiċi newrotossiċi oħrajn jew ma’ irradjazzjoni kranjali/tas-sinsla tad-dahar jista’ jżid ir-riskju ta’ newrotossiċità.

teratogenicity was characterised by partially ossified cranial bones, absence of eye sockets, hydrocephaly, bipartite sternebrae, missing lumbar vertebrae.
it-teratoġeniċità kienet ikkaratterizzata minn għadam fir-ras mhux ossifikat għal kollox, nuqqas ta’ ħofor għall-għajnejn, idroċefalu, bipartite sternebrae, rkiekel lumbari nieqsa.

cranial nerve palsies, vocal cord paresis, and rare reports of severe hypersensitivity reactions have been reported during post-marketing surveillance of abraxane.
palsi tan-nervituri tal-kranju, paresi tal-kordi vokali, u rapporti rari ta’ reazzjonijiet severi ta’ sensittività eċċessiva waqt is-sorveljanza ta’ wara t-tqegħid fis-suq ta’ abraxane.

common: cauda equina syndrome, convulsions, cranial nerve palsies, hypoesthesia, myelopathy, paresthesia, hemiplegia, numbness
komuni: sindromu ta’ cauda equina, konvulżjonijiet, puplesija tan-nerv kranjali, ipoestesija, majelopatija, parestesija, hemipleġja, tirżiħ

other adverse drug reactions may be considered somatropin class effects, such as possible hyperglycaemia caused by decreased insulin sensitivity, decreased free thyroxin level and benign intra-cranial hypertension.
reazzjonijiet avversi oħra tal-mediċina jistgħu jiġu kkunsidrati bħala effetti tal-klassi ta’ somatropin, bħal ipergliċemija possibbli kkawżata minn tnaqqf is-sensittività għall-insulina, tnaqqis fil-livell ta’ thyroxin ħieles u pressjoni għolja beninna intrakranjali.

hold the catheter at its base using a sterile technique, pinch and hold the skinfold cranial to, or overlying the patient’s supra-iliac crest with two fingers.
Żomm il-kateter mill-qiegħ tiegħu permezz ta’ teknika sterili, oqros u żomm il-liwi tal-ġilda (skinfold cranial) b’żewġt iswaba’ sa, jew sakemm tiġi fuq is-supra-iliac crest tal-pazjent.

reduced blinking following xeomin injection into the orbicularis muscle can lead to corneal exposure, persistent epithelial defects and corneal ulceration, especially in patients with cranial nerve disorders (facial nerve).
teptip ta ’ l- għajnejn imnaqqas wara l- injezzjoni b’ xeomin ġol- muskolu orbicularis jista ’ jwassal li tinkixef il- kornea, difetti epiteljali persistenti u ulċerazzjoni tal- kornea, speċjalment 19 f’ pazjenti b’ disturbi tan- nervaturi kranjali (nervaturi tal- wiċċ).

gadovist/ gadograf was approved for “ contrast enhancement in cranial and spinal magnetic resonance imaging” in germany in january 2000 and subsequently in june 2000 in the eu and norway via the mutual recognition procedure (mrp).
gadovist/ gadograf kien approvat għal "tisħiħ tal- kuntrast fl- immaġini bir- reżonanza manjetika (mri) tal- kranju u tas- sinsla ” fil- Ġermanja f' jannar 2000 u sussegwetament f' Ġunju 2000 fl- ue u fin- norveġja permezz tal- proċedura ta 'rikonoxximent reċiproku (mrp).